FDA Expands Use Of HPV Vaccine Gardasil For Vaginal, Vulvar Cancer Prevention

FDA on Friday approved expanding the use of Merck’s human papillomavirus vaccine Gardasil to protect against cancers of the vagina and vulva, the AP/MSNBC.com reports (AP/MSNBC.com, 9/12). According to an FDA

More: continued here

Filed under: Cervical Cancer on October 1st, 2008